These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 378337)

  • 1. Live influenza vaccine: screening of attenuated virus strains by a 50% ciliary activity inhibition test in organ cultures of ferret trachea.
    Boudreault A
    Can J Microbiol; 1979 Mar; 25(3):279-84. PubMed ID: 378337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of ciliary activity in organ cultures of ferret trachea in reference to genetic and biological characters in influenza virus strains.
    Diaz-Rodriguez P; Boudreault A
    Can J Microbiol; 1982 Jul; 28(7):809-14. PubMed ID: 6756625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro markers for measuring residual virulence for men of live attenuated influenza viruses.
    Boudreault A; Diaz-Rodriguez P; Lecomte J
    Dev Biol Stand; 1977 Jun 1-3; 39():33-40. PubMed ID: 604117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An 'in vitro' marker of attenuation for live influenza virus vaccine candidates.
    Mostow SR; Flatauer S; Martinko J
    Dev Biol Stand; 1975; 28():354-62. PubMed ID: 1126579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Criteria in the evaluation of live intranasal influenza virus vaccines.
    Zygraich N
    Dev Biol Stand; 1976; 33():141-50. PubMed ID: 782962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temperature-sensitive mutants of influenza virus. XIII. Evaluation of influenza A/Hong Kong/68 and A/Udorn/72 ts and wild-type viruses in tracheal organ culture at permissive and restrictive temperatures.
    Mostow SR; Flatauer S; Paler M; Murphy BR
    J Infect Dis; 1977 Jul; 136(1):1-6. PubMed ID: 886200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and efficacy of the monovalent, trivalent and quadrivalent intranasal live attenuated influenza vaccines containing different pdmH1N1 strains.
    Yeolekar LR; Ganguly M; Tyagi P; Ingle NB; Stittelaar KJ; Waal L; Scorza FB; Mahmood K; Dhere RM
    Vaccine; 2018 Nov; 36(46):6944-6952. PubMed ID: 30322745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavior of vaccine revertants of temperature-sensitive mutants of influenza virus in ferret tracheal organ culture.
    Mostow SR; Hopkins JA; Wright PF
    Infect Immun; 1979 Oct; 26(1):193-6. PubMed ID: 500202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets.
    Suguitan AL; McAuliffe J; Mills KL; Jin H; Duke G; Lu B; Luke CJ; Murphy B; Swayne DE; Kemble G; Subbarao K
    PLoS Med; 2006 Sep; 3(9):e360. PubMed ID: 16968127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential infection or immunization of ferrets with a series of influenza A (H3N2) strains (report to the Medical Research Council's Sub-Committee on influenza Vaccines (CDVIP/IV)).
    Potter CW; Jennings R; Ali MJ; Wood JM; Dunleavy U; Tyrrell DA
    Epidemiol Infect; 1987 Oct; 99(2):501-15. PubMed ID: 3315713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of ferrets to infection with a live attenuated influenza virus and to subsequent heterologous challenge.
    Delem A
    Dev Biol Stand; 1976; 33():226-33. PubMed ID: 955269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 2. Long-term immunity.
    Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA
    J Hyg (Lond); 1983 Jun; 90(3):361-70. PubMed ID: 6863910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of the immunogenicity of trivalent inactivated whole-virion influenza vaccine in human volunteers.
    Moffat MA; Pennington TH; Robertson AM; van Voorthuizen WF
    J Biol Stand; 1982 Apr; 10(2):83-90. PubMed ID: 7096364
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunity.
    Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA
    J Hyg (Lond); 1983 Jun; 90(3):351-9. PubMed ID: 6863909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trials with intranasally administered WRL 105 strain live influenza vaccine in volunteers.
    Freestone DS
    Dev Biol Stand; 1976; 33():207-12. PubMed ID: 782971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses.
    Li S; Liu C; Klimov A; Subbarao K; Perdue ML; Mo D; Ji Y; Woods L; Hietala S; Bryant M
    J Infect Dis; 1999 May; 179(5):1132-8. PubMed ID: 10191214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunity to influenza virus infection induced by heterologous, inactivated vaccines.
    Potter CW; Jennings R; Nicholson K
    Med Microbiol Immunol; 1978 Nov; 166(1-4):99-108. PubMed ID: 723794
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunity to influenza in ferrets. XIV: Comparative immunity following infection or immunization with live or inactivated vaccine.
    Fenton RJ; Clark A; Potter CW
    Br J Exp Pathol; 1981 Jun; 62(3):297-307. PubMed ID: 7018552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific immunity to influenza virus in ferret organ cultures.
    Cogliano RC; Small PA
    Br J Exp Pathol; 1978 Feb; 59(1):21-31. PubMed ID: 638028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trials with Alice strain, live, attenuated, serum inhibitor-resistant intranasal influenza A vaccine.
    Spencer MJ; Cherry JD; Powell KR; Sumaya CV; Garakian AJ
    J Infect Dis; 1975 Oct; 132(4):415-20. PubMed ID: 1102614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.